Mononucleosis Diagnostic Market Research Report To 2022: Grand View Research, Inc.

Global mononucleosis diagnostic market is expected to witness lucrative growth over the coming seven years due to increasing mononucleosis epidemics and advent of newer diagnostic facilities. Moreover, increasing health awareness amongst population base, collateral effect of other disease epidemics such as AIDS, strep throat is anticipated to drive segment growth in near future. With an advent of emerging diagnostic technological concepts such as chemiluminescence technology, chromatographic immunoassay, Reverse Transcriptase-Polymerise Chain Reaction (RT-PCR), immuno-latex test, flow cytometry, differential light scattering, bioluminescence, DNA probes, and solid phase immunoassay facilitating qualitative detection, reduced use of antibiotics and error minimization are anticipated to drive substantial growth to the mononucleosis diagnostic market over the forecast period.

For More Information on “Mononucleosis Diagnostic Market Research Reports” visit – http://www.grandviewresearch.com/industry-analysis/mononucleosis-diagnostic-market

The overall mononucleosis market is segmented on the basis of types of tests such as monospot tests, CBC Tests and Epstein Barr Virus antibody tests. Monospot test held the largest share attributing to factors such as rapid detection of antibody, accuracy and cost efficiency. EBV antibody test market is the emerging test market used in case of incidences of failure of monospot tests and as it distinguishes the susceptibility, severity and extent of vulnerability of patients towards the disease. North America held the largest share of this market pertaining to the factors such as extensive network of distribution by suppliers, advanced technology, incidence of epidemics, testing facilities. According to Centres for Disease Control and Prevention (CDC), nearly 25% of the children are mononucleosis patients responsible to cause epidemics among adults in this region. Asia pacific region is expected to witness substantial growth rate over the forecast period due to increasing epidemics, government initiatives for eradication of diseases, sanitary & living conditions of the emerging economies.

Some key players operating in this market are Genzyme, Daiichi, Hemagen, GeneTac, Biotest, Abbott Laboratories, Roche, Becton Dickinson, Diasorin, Alere, Digene, Meridian, Bio-Rad, and Zenith Johnson & Johnson. These companies develop and incorporate innovative products such as Mono II Tests by Alere, LIAISON EBV IgM by DiaSorin, ACON Mononucleosis test strips and devices, and many others available in the market. These devices are approved by the U.S. FDA and suitable for use by practitioners. Moreover, mergers and acquisitions are further expected to provide growth potential to mononucleosis thereby leading to market expansion and overcoming risks & barriers over the forecast period.

Request TOC of “Mononucleosis Diagnostic Market Research Reports” visit – http://www.grandviewresearch.com/industry-analysis/mononucleosis-diagnostic-market/request-toc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States

Phone:  1-415-349-0058

Toll Free:  1-888-202-9519

Email:  sales@grandviewresearch.com

Website: Grand View Research

Blog Site: http://www.divog.org/